Stockscreener 앱 받기
8.22
1.11%
0.09
시간 외 거래:
8.22
전일 마감가:
$8.13
열려 있는:
$8.15
하루 거래량:
1.30M
Relative Volume:
0.87
시가총액:
$713.47M
수익:
-
순이익/손실:
$-168.09M
주가수익비율:
-3.788
EPS:
-2.17
순현금흐름:
$-138.01M
1주 성능:
+4.05%
1개월 성능:
+29.25%
6개월 성능:
+11.53%
1년 성능:
-58.23%
1일 변동 폭
$8.15
$8.48
1주일 범위
$7.8561
$8.5199
52주 변동 폭
$5.41
$21.40
Kura Oncology Inc Stock (KURA) Company Profile
명칭
Kura Oncology Inc
전화
(858) 500-8800
주소
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
KURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
8.22 | 705.66M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | Guggenheim | Neutral |
| 2025-02-06 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-14 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-22 | 개시 | Mizuho | Buy |
| 2023-08-11 | 개시 | BofA Securities | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Perform |
| 2023-05-17 | 개시 | BTIG Research | Buy |
| 2023-01-31 | 개시 | Stifel | Buy |
| 2022-07-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-02-15 | 개시 | Jefferies | Buy |
| 2021-05-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-11-05 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 개시 | Credit Suisse | Outperform |
| 2020-05-05 | 개시 | Barclays | Overweight |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2018-11-09 | 개시 | Piper Jaffray | Overweight |
| 2018-08-01 | 개시 | H.C. Wainwright | Buy |
| 2016-10-13 | 재개 | Leerink Partners | Outperform |
| 2016-01-22 | 개시 | JMP Securities | Mkt Outperform |
| 2015-12-30 | 개시 | Oppenheimer | Outperform |
| 2015-12-16 | 개시 | Citigroup | Buy |
모두보기
Kura Oncology Inc 주식(KURA)의 최신 뉴스
Market reaction to Kura Oncology Inc.’s recent newsJuly 2025 Patterns & Capital Efficiency Focused Ideas - Newser
Does Kura Oncology Inc. align with a passive investing strategyJuly 2025 Trends & Weekly Watchlist for Consistent Profits - خودرو بانک
Can Kura Oncology Inc. benefit from deglobalization2025 Sector Review & Risk Managed Investment Strategies - خودرو بانک
Is it time to cut losses on Kura Oncology Inc.2025 Sector Review & Weekly High Conviction Ideas - Newser
Why is Kura Oncology Inc. stock going up2025 Trading Recap & Weekly Stock Performance Updates - خودرو بانک
Can machine learning forecast Kura Oncology Inc. recoveryTrade Risk Summary & Free Growth Oriented Trading Recommendations - Newser
Kura Flat on Inducement Awards - Baystreet.ca
Heatmap analysis for Kura Oncology Inc. and competitorsGap Up & Fast Entry Momentum Trade Alerts - Newser
Leading vs lagging indicators on Kura Oncology Inc. performanceJuly 2025 Breakouts & AI Based Trade Execution Alerts - Newser
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Kura Oncology Grants Stock Options to New Employees Under Inducement Plan - AInvest
82,950 Shares: Kura Oncology Awards Stock Options to New Cancer Drug Development Team - Stock Titan
Is Kura Oncology Inc. in a long term uptrend2025 Volume Leaders & Weekly Top Stock Performers List - خودرو بانک
Short interest data insights for Kura Oncology Inc.Weekly Trading Summary & Community Verified Trade Signals - Newser
Comparing Kura Oncology Inc. in custom built stock radarsInsider Buying & Comprehensive Market Scan Insights - Newser
Is Kura Oncology Inc. gaining market share2025 Top Decliners & Low Risk High Win Rate Stock Picks - خودرو بانک
Is this a good reentry point in Kura Oncology Inc.2025 Short Interest & Reliable Momentum Entry Alerts - Newser
Kura Oncology at Cantor Conference: Promising Pipeline and Strategic Vision By Investing.com - Investing.com Canada
Guggenheim initiates coverage on Kura Oncology stock with Neutral rating By Investing.com - Investing.com Canada
Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth - Benzinga
Should you wait for a breakout in Kura Oncology Inc.July 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Backtesting results for Kura Oncology Inc. trading strategiesJobs Report & Long Hold Capital Preservation Plans - Newser
How to use a screener to detect Kura Oncology Inc. breakoutsOil Prices & AI Forecast Swing Trade Picks - Newser
What data driven models say about Kura Oncology Inc.’s future - Newser
Using RSI to spot recovery in Kura Oncology Inc.July 2025 Macro Moves & Free Technical Pattern Based Buy Signals - Newser
Will Kura Oncology Inc. outperform tech stocksTreasury Yields & Verified Swing Trading Watchlists - خودرو بانک
Is Kura Oncology Inc. stock poised for growthJuly 2025 Selloffs & Free High Return Stock Watch Alerts - Newser
Can Kura Oncology Inc. reach resistance levels soonJuly 2025 Levels & Real-Time Volume Spike Alerts - خودرو بانک
What are Kura Oncology Inc.’s technical support levels2025 Valuation Update & Breakout Confirmation Alerts - خودرو بانک
Kura Oncology to Host Events Showcasing Preclinical and Clinical Data on FTI Agents and Targeted Therapies - Quiver Quantitative
Real time scanner hits for Kura Oncology Inc. explainedWeekly Trade Recap & Daily Risk Controlled Trade Plans - Newser
Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program - The Manila Times
First Clinical Data: Kura's Next-Gen Cancer Drug KO-2806 Shows Promise in Multiple Tumor Types - Stock Titan
Kura Oncology Inc. stock trend outlook and recovery pathJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
Aug Spikes: Can Kura Oncology Inc. benefit from deglobalizationJuly 2025 Update & Stepwise Trade Signal Implementation - khodrobank.com
Real time alert setup for Kura Oncology Inc. performanceJuly 2025 Weekly Recap & High Conviction Buy Zone Alerts - Newser
Is Kura Oncology Inc. stock risky to hold nowBreakout Watch & Free High Accuracy Swing Entry Alerts - خودرو بانک
Can Kura Oncology Inc. disrupt its industryInsider Selling & Weekly Watchlist of Top Performers - خودرو بانک
Top chart patterns to watch in Kura Oncology Inc.Weekly Profit Recap & Free Long-Term Investment Growth Plans - Newser
Tools to assess Kura Oncology Inc.’s risk profileMarket Volume Summary & Free AI Powered Buy and Sell Recommendations - Newser
Kura Oncology Inc. stock daily chart insightsJuly 2025 Selloffs & Consistent Income Trade Ideas - Newser
Has Kura Oncology Inc. found a price floor2025 Earnings Impact & Short-Term Trading Opportunity Alerts - Newser
Kura Oncology Inc (KURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Kura Oncology Inc 주식 (KURA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| WILSON TROY EDWARD | President and CEO |
Aug 13 '25 |
Buy |
6.64 |
13,494 |
89,623 |
50,968 |
| Bair Teresa Brophy | Chief Legal Officer |
May 19 '25 |
Sale |
5.96 |
1,559 |
9,292 |
107,948 |
| FORD KATHLEEN | Chief Operating Officer |
May 19 '25 |
Sale |
6.28 |
1,558 |
9,777 |
21,367 |
1.40%
자본화:
|
볼륨(24시간):